永利总站ylzz欢迎你
En
中文
English
Home
About Us
Company Profile
Chairman's speech
Company Memorabilia
Leadership care
Honor
Cultural vision
Contact Us
News
Company News
Industry News
Investor Relations
Company Overview
Company Announcement
Products and services
Intermediates
APIs
Generic drugs
Big health food
R & D innovation
Scientific research results
Quality and Safety
Innovation dynamics
HR
Training and development
Incentive guarantee
Recruitment
Menu
CN
EN
Home
About Us
Company Profile
Chairman's speech
Company Memorabilia
Leadership care
Honor
Cultural vision
Contact Us
News
Company News
Industry News
Investor Relations
Company Overview
Company Announcement
Products and services
Intermediates
APIs
Generic drugs
Big health food
R & D innovation
Scientific research results
Quality and Safety
Innovation dynamics
HR
Training and development
Incentive guarantee
Recruitment
Intermediates
APIs
Generic drugs
Big health food
APIs
Intermediates
APIs
Generic drugs
Big health food
APIs
2021-10-11
Solifenacin Succinate
2021-10-11
Apremilast
2021-10-11
Mirabegron
2021-10-11
Tofacitinib Citrate
2021-10-11
Empagliflozin
2021-10-11
Canagliflozin Hemihydrate
2021-10-10
Duloxetine HCl
2021-10-10
Levetiracetam
2021-10-09
Ozenoxacin
« Previous
1
2
Next »
Address:No.15 Shuangfeng Rd., Fotang, Yiwu, Zhejiang 322002, China
Copyright © 2021 Zhejiang Huayi Pharmaceutical Co., Ltd. All rights reserved.
ICPNo. 浙05012164
About Us
Company Profile
Chairman's speech
Company Memorabilia
Leadership care
Honor
Cultural vision
Contact Us
News
Company News
Industry News
Investor Relations
Company Overview
Company Announcement
Products and services
Intermediates
APIs
Generic drugs
Big health food
R & D innovation
Scientific research results
Quality and Safety
Innovation dynamics
HR
Training and development
Incentive guarantee
Recruitment
Copyright © 2021 Zhejiang Huayi Pharmaceutical Co., Ltd.
ICPNo. 浙05012164
by:e7cn.net
关闭
客服中心
工作时间
周一至周日
8:00 - 18:00
请直接QQ联系!
展开客服